Redeeming Value

We're always more interested in ASCO presentations that focus on spending and prices than we are about the next great breakthrough -- we're stay-in-your-line types -- so we were excited to see new research quantifying the impact of oral oncology medicines on overall spending and out-of-pocket spending.  It turns out that both of those types of spending skyrocketed between 2011 and 2016, and we spoke with MD Anderson's Meng Li, who will present the underlying data this weekend at ASCO, about the findings.